Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,380 | -1,628 | -1,236 | -574 | -4,563 |
| Depreciation Amortization | 686 | 60 | 34 | 2 | 357 |
| Other Working Capital | 1,107 | 766 | 492 | -2 | 3,202 |
| Other Operating Activity | 206 | 548 | 530 | 464 | 229 |
| Operating Cash Flow | $-381 | $-253 | $-180 | $-110 | $-775 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -28 | -16 | -5 | -6 | -44 |
| Other Investing Activity | -28 | -16 | -5 | -6 | -44 |
| Investing Cash Flow | $-28 | $-16 | $-5 | $-6 | $-44 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 264 | 215 | 110 | 100 | N/A |
| Debt Issued | 62 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 63 | 63 | 63 | N/A | 550 |
| Financing Cash Flow | $389 | $278 | $173 | $100 | $550 |
| Beginning Cash Position | 26 | 26 | 26 | 26 | 295 |
| End Cash Position | 5 | 35 | 14 | 10 | 26 |
| Net Cash Flow | $-21 | $9 | $-13 | $-16 | $-269 |
| Free Cash Flow | |||||
| Operating Cash Flow | -381 | -253 | -180 | -110 | -775 |
| Free Cash Flow | -381 | -253 | -180 | -110 | -775 |